148 related articles for article (PubMed ID: 34861571)
1. Social isolation, residential stability, and opioid use disorder among older Medicare beneficiaries: Metropolitan and non-metropolitan county comparison.
Yang TC; Shoff C; Kim S
Soc Sci Med; 2022 Jan; 292():114605. PubMed ID: 34861571
[TBL] [Abstract][Full Text] [Related]
2. Neighborhood characteristics and opioid use disorder among older Medicare beneficiaries: An examination of the role of the COVID-19 pandemic.
Yang TC; Shoff C; Shaw BA; Strully K
Health Place; 2023 Jan; 79():102941. PubMed ID: 36442317
[TBL] [Abstract][Full Text] [Related]
3. County social isolation and opioid use disorder among older adults: A longitudinal analysis of Medicare data, 2013-2018.
Yang TC; Shoff C; Kim S; Shaw BA
Soc Sci Med; 2022 May; 301():114971. PubMed ID: 35430465
[TBL] [Abstract][Full Text] [Related]
4. Social Vulnerability and the Prevalence of Opioid Use Disorder Among Older Medicare Beneficiaries in U.S. Counties.
Yang TC; Kim S; Matthews SA; Shoff C
J Gerontol B Psychol Sci Soc Sci; 2023 Dec; 78(12):2111-2121. PubMed ID: 37788567
[TBL] [Abstract][Full Text] [Related]
5. Multiscale dimensions of county-level disparities in opioid use disorder rates among older Medicare beneficiaries.
Yang TC; Shoff C; Choi SE; Sun F
Front Public Health; 2022; 10():993507. PubMed ID: 36225787
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder.
Nguyen T; Andraka-Christou B; Simon K; Bradford WD
JAMA Netw Open; 2019 Dec; 2(12):e1916520. PubMed ID: 31790568
[TBL] [Abstract][Full Text] [Related]
7. Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries.
Moyo P; Eliot M; Shah A; Goodyear K; Jutkowitz E; Thomas K; Zullo AR
Addict Sci Clin Pract; 2022 Oct; 17(1):57. PubMed ID: 36209151
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
9. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
10. Association of Urban-Rural Residence and Concurrent HIV Infection and Opioid Use Disorder Among Medicare Beneficiaries-United States, 2020.
Chang MH; Moonesinghe R; Truman BI
J Health Care Poor Underserved; 2022; 33(2):918-933. PubMed ID: 35574885
[TBL] [Abstract][Full Text] [Related]
11. Association of Opioid Use Disorder Diagnosis With Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis.
Moyo P; Merlin JS; George M; Shireman TI; Marshall BDL
J Pain; 2024 Mar; 25(3):742-754. PubMed ID: 37820847
[TBL] [Abstract][Full Text] [Related]
12. Opioid Use Disorder Among the Economically Disadvantaged in the Rural South.
Albright DL; Suntai Z; McDaniel JT; Johnson K; Henson H; Robertson E; McIntosh S
J Addict Med; 2023 Jul-Aug 01; 17(4):418-423. PubMed ID: 37579099
[TBL] [Abstract][Full Text] [Related]
13. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
Abraham AJ; Adams GB; Bradford AC; Bradford WD
Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
[TBL] [Abstract][Full Text] [Related]
14. Opioid use disorder among hospitalized adults in North Carolina: Comparative analysis of national and statewide trends.
Alemu BT; McCague EA; Holt N; Baron PA; Olayinka O; Martin BC
J Opioid Manag; 2021; 17(4):343-352. PubMed ID: 34533829
[TBL] [Abstract][Full Text] [Related]
15. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
[TBL] [Abstract][Full Text] [Related]
16. Psycho-Social Correlates of Opioid Use Disorder among the US Adult Population: Evidence from the National Survey on Drug Use and Health, 2015-2018.
Haider MR; Brown MJ; Gupta RD; Karim S; Olatosi B; Li X
Subst Use Misuse; 2020; 55(12):2002-2010. PubMed ID: 32633664
[TBL] [Abstract][Full Text] [Related]
17. Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.
Felix C; Sharfstein JM; Olsen Y
J Am Geriatr Soc; 2020 Mar; 68(3):637-640. PubMed ID: 31825528
[TBL] [Abstract][Full Text] [Related]
18. The association between the supply of select nonpharmacologic providers for pain and use of nonpharmacologic pain management services and initial opioid prescribing patterns for Medicare beneficiaries with persistent musculoskeletal pain.
Karmali RN; Skinner AC; Trogdon JG; Weinberger M; George SZ; Hassmiller Lich K
Health Serv Res; 2021 Apr; 56(2):275-288. PubMed ID: 33006158
[TBL] [Abstract][Full Text] [Related]
19. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
[TBL] [Abstract][Full Text] [Related]
20. Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study.
Lo-Ciganic WH; Huang JL; Zhang HH; Weiss JC; Kwoh CK; Donohue JM; Gordon AJ; Cochran G; Malone DC; Kuza CC; Gellad WF
PLoS One; 2020; 15(7):e0235981. PubMed ID: 32678860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
